SCHEMBL11338954

SCHEMBL11338954

Cc1ccc(NC(=O)Nc2ccc(C)c(C(=O)Nc3cc(S(=O)(=O)O)cc4cccc(O)c34)c2)cc1C(=O)Nc1cc(S(=O)(=O)O)cc2cccc(O)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APEX1 P27695 1/20 0.49
▸ PRMT1 Q99873 2/20 0.48
▸ KMT2A Q03164 5/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ HPSE Q9Y251 2/20 0.44
▸ USP2 O75604 2/20 0.44
▸ TIMP3 P35625 2/20 0.44
▸ RECQL P46063 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ KDR P35968 2/20 0.44
▸ ENPP3 O14638 1/20 0.44
▸ ENTPD3 O75355 1/20 0.44
▸ NR1I2 O75469 1/20 0.44
▸ PRKD3 O94806 1/20 0.44
▸ TDP2 O95551 1/20 0.44
▸ CBX7 O95931 1/20 0.44
▸ NSD2 O96028 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ PRKCG P05129 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10908110 0.94 APEX1 (0.49) APEX1PRMT1KMT2AMEN1HPSE
SCHEMBL11350863 0.92 PRMT1 (0.51) APEX1PRMT1KMT2AMEN1HPSE
SCHEMBL11588083 0.90 APEX1 (0.58) APEX1PRMT1KMT2AMEN1HPSE
SCHEMBL10905228 0.85 APEX1 (0.49) APEX1PRMT1KMT2AMEN1HPSE
SCHEMBL11512944 0.85 TIMP3 (0.52) APEX1PRMT1KMT2AMEN1HPSE
SCHEMBL11347076 0.84 APEX1 (0.63) APEX1PRMT1KMT2AMEN1HPSE
SCHEMBL11339227 0.83 APEX1 (0.62) APEX1PRMT1KMT2AMEN1HPSE
SCHEMBL10823395 0.82 IDH1 (0.53) —
SCHEMBL11347958 0.81 PRMT1 (0.53) PRMT1KMT2AMEN1HPSEUSP2
SCHEMBL11347884 0.80 KMT2A (0.49) APEX1PRMT1KMT2AMEN1HPSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 — — US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 — — EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 — — US disclosed
Send feedback